<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00127790</url>
  </required_header>
  <id_info>
    <org_study_id>160743209</org_study_id>
    <secondary_id>F32NS049789</secondary_id>
    <secondary_id>K23NR010408</secondary_id>
    <secondary_id>R21AG023956; R24AG031089</secondary_id>
    <secondary_id>R21AG023956</secondary_id>
    <nct_id>NCT00127790</nct_id>
  </id_info>
  <brief_title>Treatment of Insomnia Secondary to Chronic Pain</brief_title>
  <official_title>CBT for Co-Morbid Insomnia and Chronic Pain: Sleep, Pain and Immune Function Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Nursing Research (NINR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several studies have shown that behavioral therapy for chronic pain can be beneficial for
      chronic pain and that behavioral therapy for insomnia can be beneficial for insomnia.
      However, seldom do chronic pain patients with insomnia receive a behavioral treatment for
      insomnia. The purpose of this study is to evaluate whether treatment for insomnia is helpful
      for pain and whether treatment for pain is helpful for insomnia. It will also assess whether
      a combined treatment is any more or less effective for pain or for sleep. Finally, the study
      will assess whether any of these treatments leads to improvements in immune function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators' primary goal is to assess the extent to which three forms of
      cognitive-behavioral treatment (CBT for insomnia, CBT for pain, and combined insomnia &amp; pain)
      diminishes insomnia symptoms in patients with chronic pain compared to a group not receiving
      CBT. This will be evaluated in a randomized trial with before and after evaluations using
      standard sleep diary measures of sleep continuity.

      The investigators' secondary goal is to assess whether treatment responses to any of the
      interventions are associated with alterations in immune function.

      The investigators' tertiary goals are to evaluate whether improved sleep has effects on
      patient reports of pain severity, frequency, and tolerability as well as on mood and quality
      of life.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insomnia Severity</measure>
    <time_frame>Pre to Post Treatment Change (Over an average of approximately 10 weeks)</time_frame>
    <description>Total Score from the 7-item Insomnia Severity Index where total score ranges from 0-28 and higher scores indicate greater severity of insomnia.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Severity</measure>
    <time_frame>Pre to Post Treatment Change (Over an average of approximately 10 weeks)</time_frame>
    <description>Multidimensional Pain Inventory - Pain Severity SubScale score. The subscale consists of 3 items with a total subscale score ranging from 0-18 with higher values indicating greater pain severity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IL-6</measure>
    <time_frame>Pre to Post Treatment Change (Over an average of approximately 10 weeks)</time_frame>
    <description>Circulating levels of Interleukin-6 (IL-6)from plasma drawn in the morning. Values are presented as picograms per milliliter (pg/mL) and can range from 0 to 500, though tend to be in the range of 0-10. Higher values indicate higher amounts of circulating levels of IL-6, a marker of increased inflammatory processes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depression Severity</measure>
    <time_frame>Pre to Post Treatment Chnage (Over an average of approximately 10 weeks)</time_frame>
    <description>Total score from the 20-item Center for Epidemiologic Studies Depression Scale-revised where the total score ranges from 0-60 and higher scores indicate greater depression severity.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Insomnia</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>CBT for Insomnia (CBT-I)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cognitive-Behavioral Therapy for Insomnia (CBT-I)consisting of 10 individual sessions and including sleep education, sleep restriction therapy, stimulus control therapy, sleep hygiene, cognitive therapy, relaxation training and relapse prevention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CBT for Pain (CBT-P)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cognitive-Behavioral Therapy for Pain (CBT-P)consisting of 10 individual sessions and including pain education, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CBT for Insomnia &amp; Pain (CBT-I/P)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combined Cognitive-Behavioral Therapy for Insomnia &amp; Cognitive-Behavioral Therapy for Pain (CBT-I/P)over 10 individual sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait-List Control (WL)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Waitlist Control condition (WL) with no contact during the intervention period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CBT for Insomnia (CBT-I)</intervention_name>
    <arm_group_label>CBT for Insomnia (CBT-I)</arm_group_label>
    <arm_group_label>CBT for Insomnia &amp; Pain (CBT-I/P)</arm_group_label>
    <other_name>Cognitive-Behavioral Therapy for Insomnia (CBT-I)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CBT for Pain (CBT-P)</intervention_name>
    <arm_group_label>CBT for Pain (CBT-P)</arm_group_label>
    <arm_group_label>CBT for Insomnia &amp; Pain (CBT-I/P)</arm_group_label>
    <other_name>Cognitive-Behavioral Therapy for Pain (CBT-P)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 35-75

          -  Chronic non-malignant painful condition of the spine of &gt; 6 months duration

          -  Insomnia (&gt; 30 minutes sleep latency and/or wake after sleep onset time for &gt; 3
             days/week for &gt; 6 months)

          -  Insomnia developed after the onset of the painful condition

          -  Preferred sleep phase between 10:00 p.m. and 8:00 am

          -  On stable medical regimen for medical and pain conditions (no surgery planned)

          -  Willingness to discontinue hypnotic medications

        Exclusion Criteria:

          -  Unstable medical or psychiatric illness

          -  History of seizures

          -  Evidence of active illicit substance use or fitting criteria for ethanol (ETOH) abuse
             or dependence

          -  Symptoms suggestive of sleep disorders other than insomnia

          -  Polysomnographic data indicating sleep disorders other than insomnia

          -  Inadequate language comprehension

          -  Fibromyalgia

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wilfred R. Pigeon, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Rochester Sleep Research Laboratory</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2005</study_first_submitted>
  <study_first_submitted_qc>August 4, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2005</study_first_posted>
  <results_first_submitted>June 12, 2012</results_first_submitted>
  <results_first_submitted_qc>September 14, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 17, 2012</results_first_posted>
  <last_update_submitted>September 14, 2012</last_update_submitted>
  <last_update_submitted_qc>September 14, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 17, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>Wilfred Pigeon</investigator_full_name>
    <investigator_title>Asst Prof</investigator_title>
  </responsible_party>
  <keyword>Insomnia</keyword>
  <keyword>Sleep</keyword>
  <keyword>Pain</keyword>
  <keyword>Pain, Chronic</keyword>
  <keyword>Behavior Therapy</keyword>
  <keyword>CBT</keyword>
  <keyword>CBT-I</keyword>
  <keyword>cognitive-behavioral</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Men and women aged 35-75 experiencing chronic pain and insomnia were recruited from the community through newspaper advertisements and from local pain clinics via recruitment flyers.</recruitment_details>
      <pre_assignment_details>Participants completed intake interview, physical exam, clinical chemistries and toxicology screens; completed daily pain-sleep diaries for two weeks; and then underwent polysomnography. Seven subjects were excluded prior to randomization (4 due to sleep apnea, 1 did not meet pain severity criteria, and 2 subsequently declined to participate).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Cognitive-Behavioral Therapy for Insomnia (CBT-I)</title>
          <description>Cognitive-Behavioral Therapy for Insomnia (CBT-I)consisting of 10 individual sessions and including sleep education, sleep restriction therapy, stimulus control therapy, sleep hygiene, cognitive therapy, relaxation training and relapse prevention.</description>
        </group>
        <group group_id="P2">
          <title>Cognitive-Behavioral Therapy for Pain (CBT-P)</title>
          <description>Cognitive-Behavioral Therapy for Pain (CBT-P)consisting of 10 individual sessions and including pain education, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
        </group>
        <group group_id="P3">
          <title>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)</title>
          <description>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)consisting of 10 individual sessions and including sleep education, pain education, sleep restriction therapy, stimulus control therapy, sleep hygiene, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
        </group>
        <group group_id="P4">
          <title>Wait-List Control (WL)</title>
          <description>Waitlist Control condition (WL) with no contact during the intervention period.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Pre-Treatment</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6">7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.</participants>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Post-Treatment</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cognitive-Behavioral Therapy for Insomnia (CBT-I)</title>
          <description>Cognitive-Behavioral Therapy for Insomnia (CBT-I)consisting of 10 individual sessions and including sleep education, sleep restriction therapy, stimulus control therapy, sleep hygiene, cognitive therapy, relaxation training and relapse prevention.</description>
        </group>
        <group group_id="B2">
          <title>Cognitive-Behavioral Therapy for Pain (CBT-P)</title>
          <description>Cognitive-Behavioral Therapy for Pain (CBT-P)consisting of 10 individual sessions and including pain education, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
        </group>
        <group group_id="B3">
          <title>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)</title>
          <description>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)consisting of 10 individual sessions and including sleep education, pain education, sleep restriction therapy, stimulus control therapy, sleep hygiene, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
        </group>
        <group group_id="B4">
          <title>Wait-List Control (WL)</title>
          <description>Waitlist Control condition (WL) with no contact during the intervention period.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
            <count group_id="B2" value="5"/>
            <count group_id="B3" value="6"/>
            <count group_id="B4" value="4"/>
            <count group_id="B5" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.7" spread="8.2"/>
                    <measurement group_id="B2" value="55.8" spread="9.8"/>
                    <measurement group_id="B3" value="50.5" spread="8.5"/>
                    <measurement group_id="B4" value="52.3" spread="1.0"/>
                    <measurement group_id="B5" value="50.7" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Insomnia Severity</title>
        <description>Total Score from the 7-item Insomnia Severity Index where total score ranges from 0-28 and higher scores indicate greater severity of insomnia.</description>
        <time_frame>Pre to Post Treatment Change (Over an average of approximately 10 weeks)</time_frame>
        <population>completed the intervention and self report instruments</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive-Behavioral Therapy for Insomnia (CBT-I)</title>
            <description>Cognitive-Behavioral Therapy for Insomnia (CBT-I)consisting of 10 individual sessions and including sleep education, sleep restriction therapy, stimulus control therapy, sleep hygiene, cognitive therapy, relaxation training and relapse prevention.</description>
          </group>
          <group group_id="O2">
            <title>Cognitive-Behavioral Therapy for Pain (CBT-P)</title>
            <description>Cognitive-Behavioral Therapy for Pain (CBT-P)consisting of 10 individual sessions and including pain education, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
          </group>
          <group group_id="O3">
            <title>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)</title>
            <description>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)consisting of 10 individual sessions and including sleep education, pain education, sleep restriction therapy, stimulus control therapy, sleep hygiene, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
          </group>
          <group group_id="O4">
            <title>Wait-List Control (WL)</title>
            <description>Waitlist Control condition (WL) with no contact during the intervention period.</description>
          </group>
        </group_list>
        <measure>
          <title>Insomnia Severity</title>
          <description>Total Score from the 7-item Insomnia Severity Index where total score ranges from 0-28 and higher scores indicate greater severity of insomnia.</description>
          <population>completed the intervention and self report instruments</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="6"/>
                <count group_id="O4" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" spread="1.9"/>
                    <measurement group_id="O2" value="12.8" spread="1.1"/>
                    <measurement group_id="O3" value="4.4" spread="1.0"/>
                    <measurement group_id="O4" value="13.0" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-tailed comparison of pre-post scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.010</p_value>
            <method>Generalized Estimating Equations</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>7.0</param_value>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-tailed comparison of pre-post scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.581</p_value>
            <method>Generalized Estimating Equations</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.5</param_value>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-tailed comparison of pre-post scores</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.011</p_value>
            <method>Generalized Estimating Equations</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>8.6</param_value>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Severity</title>
        <description>Multidimensional Pain Inventory - Pain Severity SubScale score. The subscale consists of 3 items with a total subscale score ranging from 0-18 with higher values indicating greater pain severity.</description>
        <time_frame>Pre to Post Treatment Change (Over an average of approximately 10 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cognitive-Behavioral Therapy for Insomnia (CBT-I)</title>
            <description>Cognitive-Behavioral Therapy for Insomnia (CBT-I)consisting of 10 individual sessions and including sleep education, sleep restriction therapy, stimulus control therapy, sleep hygiene, cognitive therapy, relaxation training and relapse prevention.</description>
          </group>
          <group group_id="O2">
            <title>Cognitive-Behavioral Therapy for Pain (CBT-P)</title>
            <description>Cognitive-Behavioral Therapy for Pain (CBT-P)consisting of 10 individual sessions and including pain education, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
          </group>
          <group group_id="O3">
            <title>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)</title>
            <description>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)consisting of 10 individual sessions and including sleep education, pain education, sleep restriction therapy, stimulus control therapy, sleep hygiene, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
          </group>
          <group group_id="O4">
            <title>Wait-List Control (WL)</title>
            <description>Waitlist Control condition (WL) with no contact during the intervention period.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Severity</title>
          <description>Multidimensional Pain Inventory - Pain Severity SubScale score. The subscale consists of 3 items with a total subscale score ranging from 0-18 with higher values indicating greater pain severity.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="6"/>
                <count group_id="O4" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.0" spread="2.3"/>
                    <measurement group_id="O2" value="6.2" spread="1.7"/>
                    <measurement group_id="O3" value="8.8" spread="1.9"/>
                    <measurement group_id="O4" value="7.5" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-tailed comparison of pre-post scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.33</p_value>
            <method>Generalized Estimating Equations</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>3.5</param_value>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-tailed comparison of pre-post scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.112</p_value>
            <method>Generalized Estimating Equations</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.2</param_value>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-tailed comparison of pre-post scores</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.737</p_value>
            <method>Generalized Estimating Equations</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.3</param_value>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>IL-6</title>
        <description>Circulating levels of Interleukin-6 (IL-6)from plasma drawn in the morning. Values are presented as picograms per milliliter (pg/mL) and can range from 0 to 500, though tend to be in the range of 0-10. Higher values indicate higher amounts of circulating levels of IL-6, a marker of increased inflammatory processes.</description>
        <time_frame>Pre to Post Treatment Change (Over an average of approximately 10 weeks)</time_frame>
        <population>Subjects completing blood draws to obtain plasma. One subject in the CBT-I&amp;P condition did not complete blood draws.</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive-Behavioral Therapy for Insomnia (CBT-I)</title>
            <description>Cognitive-Behavioral Therapy for Insomnia (CBT-I)consisting of 10 individual sessions and including sleep education, sleep restriction therapy, stimulus control therapy, sleep hygiene, cognitive therapy, relaxation training and relapse prevention.</description>
          </group>
          <group group_id="O2">
            <title>Cognitive-Behavioral Therapy for Pain (CBT-P)</title>
            <description>Cognitive-Behavioral Therapy for Pain (CBT-P)consisting of 10 individual sessions and including pain education, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
          </group>
          <group group_id="O3">
            <title>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)</title>
            <description>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)consisting of 10 individual sessions and including sleep education, pain education, sleep restriction therapy, stimulus control therapy, sleep hygiene, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
          </group>
          <group group_id="O4">
            <title>Wait-List Control (WL)</title>
            <description>Waitlist Control condition (WL) with no contact during the intervention period.</description>
          </group>
        </group_list>
        <measure>
          <title>IL-6</title>
          <description>Circulating levels of Interleukin-6 (IL-6)from plasma drawn in the morning. Values are presented as picograms per milliliter (pg/mL) and can range from 0 to 500, though tend to be in the range of 0-10. Higher values indicate higher amounts of circulating levels of IL-6, a marker of increased inflammatory processes.</description>
          <population>Subjects completing blood draws to obtain plasma. One subject in the CBT-I&amp;P condition did not complete blood draws.</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="0.2"/>
                    <measurement group_id="O2" value="1.6" spread="1.0"/>
                    <measurement group_id="O3" value="1.2" spread="0.2"/>
                    <measurement group_id="O4" value="1.2" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-tailed comparison of pre-post scores</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.063</p_value>
            <method>Generalized Estimating Equations</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.5</param_value>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-tailed comparison of pre-post scores</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.786</p_value>
            <method>Generalized Estimating Equations</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.4</param_value>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-tailed comparison of pre-post scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.039</p_value>
            <method>Generalized Estimating Equations</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.0</param_value>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Depression Severity</title>
        <description>Total score from the 20-item Center for Epidemiologic Studies Depression Scale-revised where the total score ranges from 0-60 and higher scores indicate greater depression severity.</description>
        <time_frame>Pre to Post Treatment Chnage (Over an average of approximately 10 weeks)</time_frame>
        <population>participants who completed intervention and pre and post treatment assessments</population>
        <group_list>
          <group group_id="O1">
            <title>Cognitive-Behavioral Therapy for Insomnia (CBT-I)</title>
            <description>Cognitive-Behavioral Therapy for Insomnia (CBT-I)consisting of 10 individual sessions and including sleep education, sleep restriction therapy, stimulus control therapy, sleep hygiene, cognitive therapy, relaxation training and relapse prevention.</description>
          </group>
          <group group_id="O2">
            <title>Cognitive-Behavioral Therapy for Pain (CBT-P)</title>
            <description>Cognitive-Behavioral Therapy for Pain (CBT-P)consisting of 10 individual sessions and including pain education, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
          </group>
          <group group_id="O3">
            <title>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)</title>
            <description>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)consisting of 10 individual sessions and including sleep education, pain education, sleep restriction therapy, stimulus control therapy, sleep hygiene, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
          </group>
          <group group_id="O4">
            <title>Wait-List Control (WL)</title>
            <description>Waitlist Control condition (WL) with no contact during the intervention period.</description>
          </group>
        </group_list>
        <measure>
          <title>Depression Severity</title>
          <description>Total score from the 20-item Center for Epidemiologic Studies Depression Scale-revised where the total score ranges from 0-60 and higher scores indicate greater depression severity.</description>
          <population>participants who completed intervention and pre and post treatment assessments</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="1.9"/>
                    <measurement group_id="O2" value="10.2" spread="2.9"/>
                    <measurement group_id="O3" value="4.4" spread="1.8"/>
                    <measurement group_id="O4" value="17.6" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-tailed comparison of pre-post scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.016</p_value>
            <method>Generlaized Estimating Equations</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>15.2</param_value>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-tailed comparison of pre-post scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.187</p_value>
            <method>Generalized Estimating Equations</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>7.4</param_value>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Two-tailed comparison of pre-post scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.015</p_value>
            <method>Generalized Estimating Equations</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>13.2</param_value>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Cognitive-Behavioral Therapy for Insomnia (CBT-I)</title>
          <description>Cognitive-Behavioral Therapy for Insomnia (CBT-I)consisting of 10 individual sessions and including sleep education, sleep restriction therapy, stimulus control therapy, sleep hygiene, cognitive therapy, relaxation training and relapse prevention.</description>
        </group>
        <group group_id="E2">
          <title>Cognitive-Behavioral Therapy for Pain (CBT-P)</title>
          <description>Cognitive-Behavioral Therapy for Pain (CBT-P)consisting of 10 individual sessions and including pain education, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
        </group>
        <group group_id="E3">
          <title>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)</title>
          <description>Cognitive-Behavioral Therapy for Insomnia &amp; Pain (CBT-I/P)consisting of 10 individual sessions and including sleep education, pain education, sleep restriction therapy, stimulus control therapy, sleep hygiene, pacing strategies, problem solving, goal setting, cognitive therapy, relaxation training and relapse prevention.</description>
        </group>
        <group group_id="E4">
          <title>Wait-List Control (WL)</title>
          <description>Waitlist Control condition (WL) with no contact during the intervention period.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The foremost limitation of this pilot study is its small sample size, particularly for a four-arm design. Accordingly, a cautious approach to the interpretation of the findings is warranted.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Wilfred Pigeon, PhD</name_or_title>
      <organization>Universityy of Rochester</organization>
      <phone>(585) 275-3374</phone>
      <email>wilfred_pigeon@urmc.rochester.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

